Recursion Pharmaceuticals Linkedin, Here, data scientists and engineers work side by side with.

Recursion Pharmaceuticals Linkedin, Chad Bradford, Senior Director of Chemistry, shares Recursion’s approach to quickly generating chemistry insights – in vitro data – for Lina Nilsson is the Vice President of Product at Recursion Pharmaceuticals. Prior to joining Recursion, Mr. 🧪 Inside Recursion’s analytical chemistry lab. The industrial revolution of drug discovery is here. Dive into our team's passion, expertise, and vision. AI drug developer Recursion Pharmaceuticals Inc. I have worked at all Recursion | 85,475 followers on LinkedIn. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company Embark on a career journey with Recursion. Use the PitchBook Platform to explore the full profile. See Chris Gibson's compensation, career history, education, & memberships. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Explore Recursion's dynamic drug discovery pipeline. Live from Salt Lake City, UT, Recursion rings the Nasdaq Opening Bell in celebration of today's #RecursionIPO! #RecursionRXRX is a clinical-stage biotechnology company decoding biology by Read the biography of Matt Kinn, at Recursion Pharma as Chief Business Officer – with past positions, education, a Full bio on The Official Board. Read moer about our approach today! About Recursion Pharmaceuticals Founded in 2013, Recursion Pharmaceuticals combines experimental biology, bioinformatics, and artificial intelligence in a ‍ The Recursion Operating System (OS), Recursion's proprietary AI drug discovery and drug development platform, spans target identification to clinical trial enrollment. Stay informed with cutting-edge insights! Recursion Pharmaceuticals combines AI, machine learning, and automation to create a next-generation biopharmaceutical platform, accelerating drug Recursion | 71,359 followers on LinkedIn. , a clinical stage TechBio company decoding biology to industrialize Read the biography of David Hallett, at Recursion Pharma as Chief Scientific Officer – with past positions, educat Full bio on The Official Board. Tim is based out of Salt Lake City, Utah, United States and works in the Biotechnology --The business combination of two AI-powered drug discovery and development companies, Recursion and Exscientia has been completed, with Proud to be among great companies as Recursion ranks as one of the 500 best startups to work for across all industries according to Forbes! | 13 comments on LinkedIn Recursion Pharmaceuticals, Inc. Carpino and Genin bring their enthusiasm for chemistry and track records of success in pharma to Recursion during a period of the company's rapid expansion. AI Drug Discovery & the Future of Pharma. Full bio on The Official Board. See details & apply to join us in our Recursion | 85,357 followers on LinkedIn. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion | 71,491 followers on LinkedIn. 30 from Genetic Engineering & Biotechnology News, hear from keynote After a tough year, Exscientia will merge into Recursion, creating one company that has 10 clinical readouts expected over the next 18 months. Recursion also has offices in Toronto, Montréal and the San Stock analysis for Recursion Pharmaceuticals Inc (RXRX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Chris Gibson is CEO/Co-Founder at Recursion Pharmaceuticals LLC. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company Recursion | 85,114 followers on LinkedIn. Recursion | 71,450 followers on LinkedIn. , a digital biology company industrializing drug discovery, have Recursion | 84,286 followers on LinkedIn. Apply to work with us today! Najat Khan, Ph. View Laurie Silverson’s profile on LinkedIn, a Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the Ben is passionate about Recursion’s mission of decoding biology to radically improve lives. Dive deeper with us today! Recursion | 84,286 followers on LinkedIn. Najat Khan succeeding Chris Gibson as CEO, indicating a strategic move to maintain continuity and build Recursion | 85,174 followers on LinkedIn. As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Berlin, Germany and Salt Lake City, USA, September 9, 2020 - Bayer and US-based Recursion Pharmaceuticals, Inc. STEM education advocate. Looking forward to watching the team Liked by Matthew Pfeiffer Proud to be among great companies as Recursion ranks as one of the 500 best startups to work for across all industries according to Forbes! | 13 comments on LinkedIn We’re looking forward to connecting this week with the #NF community and scientific leaders at the 20th CPD Match Neurofibromatosis SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery and Recursion will release proof-of-concept clinical trial data over the next 12 months; investor interest in seeing if AI can speed drug development is high. Is Recursion Pharmaceuticals a Millionaire Maker? This is the only biotech stock to attract an investment from artificial intelligence (AI) giant Nvidia. · Experience: Oligon Therapeutics · Education: Temple University School of Medicine · Location: Greater Phoenix Area · 500+ connections on LinkedIn. Recursion just announced it will report second quarter 2024 business updates and financial results on August 8th. 68 m in annual revenue in FY 2025. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion Pharmaceuticals' headquarters in Salt Lake City, UT, United States As Recursion Pharmaceuticals continues to innovate in AI-driven drug discovery, its strategic partnerships and technological advancements position it Experienced IT professional with demonstrated history of delivering a quality work · Experience: Recursion Pharma · Education: Montana State University Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Additionally, Lina Nilsson has had 1 past job as the Senior Director, Data Science Product at Recursion Pharmaceuticals. , is an accomplished biopharma leader at the forefront of driving bold innovation to bring transformative therapies to patients. View Tarl McCallson, CPA’s As we continue building Recursion Pharmaceuticals, we remain as committed as ever to rare diseases and drug repurposing. Unapologetic · Experience: Recursion · Education: UC Santa Cruz · Location: · Experience: Recursion Pharmaceuticals · Education: University of Utah · Location: Salt Lake City · 500+ connections on LinkedIn. , Oct. D. Ratio nabs Novartis vet as strategy chief. Dive into opportunities, culture, and the impact you can make. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion | 84,286 followers on LinkedIn. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Salt Lake City, Jan. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion | 85,356 followers on LinkedIn. See Ben R Taylor's compensation, career history, education, & memberships. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Liked by Blake Borgeson Today marks my one-year anniversary at Recursion Pharmaceuticals. Delve into Recursion's unique TechBio approach. recursion. Learn more at Potential Positives Recursion announced a significant leadership transition with Dr. At its foundation, 🚨I’ve recently joined Vertex Pharmaceuticals as the inaugural member of the US Nephrology medical affairs team. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions. Following Tuesday’s layoffs, the biotech expects its runway to last Read the biography of Chris Gibson, at Recursion Pharma as Chairman of the Board and Director as Cellino Biotech – with More on The Official Board. See insights on Recursion Pharmaceuticals including office locations, Drs. com, or Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and Our data and the Recursion OS enable us to train intelligent machine learning models for AI drug discovery and development, which help us rapidly identify Recursion | 85,499 followers on LinkedIn. Recursion is a clinical stage TechBio company decoding biology to MD, Ph. See what employees say it's like to work at Recursion Pharmaceuticals. Explore Recursion's latest blog posts on AI, automation, and molecular modeling in drug discovery. Our approach is grounded in rigorous science and Vice President Of Medicinal Chemistry at Recursion Pharmaceuticals · Experienced Medicinal Chemist with a demonstrated history of working in the Recursion also has offices in Montréal, New York, London, and the Oxford area. Experience: Recursion Pharmaceuticals · Location: San Francisco Bay Area. 3,305 likes · 11 talking about this · 83 were here. Read more about our team today! Explore the uncharted: Careers at Recursion Who we are Recursion is a clinical stage TechBio company decoding biology to industrialize drug discovery. As one of the 100 Companies Championing Women, When it comes to using AI for pharma discovery, Recursion is the TechBio partner of choice. Discover how we're revolutionizing drug discovery and biotech. We are Recursion Pharmaceuticals（纳斯达克：RXRX）是一家以AI驱动的临床阶段TechBio公司，专注于通过解码生物学加速药物发现。 今天公司发布了2026年第一季度财报及业务更新。 整体来看，营收显著 Get acquainted with the brilliant minds behind Recursion. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines. A free inside look at company reviews and salaries posted anonymously by employees. Company Colleagues At Recursion Pharma, Brandon Probst has 34 colleagues including Najat Khan (CEO & President), Zavain Dar (Director) Industry Colleagues In the Pharmaceuticals industry, Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an Recursion refreshes leadership team with CEO swap. In a new story in Clinical Leader, Sid Jain, SVP of Clinical Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning. I suspect we are already doing more work in this space than CEO and President Najat Khan, Ph. At the inaugural “The State of AI in Drug Discovery” virtual event on Wed. ” Today, on International Women in Tech Day, we asked Lina Nilsson, SVP Head of Platform and Product at Recursion | 85. , which uses machine learning to hunt for new therapies, raised $436 million in an upsized initial public offering priced “The equation is being rewritten. 773 follower su LinkedIn. Ideal candidates have Liked by Nathan Recursion | LinkedIn 팔로워 85,393명 | Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Mar 2021 The Constellation Pharmaceuticals FIRST Award is given to employees that best exemplify Constellation's values: - Focus on serving unmet medical After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Recursion | 84,533 followers on LinkedIn. stock news by MarketWatch. View David Mauro’s profile on 166 Recursion Pharmaceuticals reviews. (RXRX) stock quote, history, news and other vital information to help you with your stock trading and Recursion | 84. View Ben Taylor’s profile on LinkedIn, a professional Chief Technology Officer at Recursion · I want to build systems (both technical & people systems!) that make the world a better place. Learn about our He established landmark partnerships with pharma leaders like Roche and Genentech, Sanofi, and Bayer, demonstrating the industry’s conviction in the “We came to London to seek the best talent in the world. REC-7735 (PI3Kα H1047R): Recursion announced progress Recursion Pharmaceuticals , a biotech firm which uses artificial intelligence to discover new drug candidates, has agreed to buy smaller rival Recursion is seeking a Head of Intellectual Property and Strategic Transactions to shape the company’s IP strategy and support high-value business development, licensing, collaboration, and Recursion is seeking a Head of Intellectual Property and Strategic Transactions to shape the company’s IP strategy and support high-value business development, licensing, collaboration, and Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Before joining Recursion Ben was a Data Scientis Recursion | 84,702 followers on LinkedIn. Salaries, reviews, and more - all posted by employees working at Recursion Exactly a year ago, our community was devastated to learn that Recursion Pharmaceuticals discontinued its REC-994 Phase 2 clinical trial for cavernous Experience: Recursion · Education: Brown University · Location: London · 500+ connections on LinkedIn. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to As Chief Business Officer at Recursion, I sit at the nexus of a multi-disciplinary effort · Experience: Recursion · Education: Northwestern University - Kellogg School of Management After 30 years in biotech and pharma, I’ve decided to take a new direction and launch FOSHE Consulting. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion will also receive an additional $30 million upfront payment from Bayer to develop new treatments for chronic scar tissue, or fibrotic, I'm hiring some critical roles in Recursion's People Team. 072 seguidores en LinkedIn. Recursion | 85,435 followers on LinkedIn. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion Pharmaceuticals is pioneering a new approach to drug discovery through the integration of automated cell biology, high-dimensional and diverse data sets, and sophisticated analytics. Here, data scientists and engineers work side by side with View Matt Peters’ profile on LinkedIn, a professional community of 1 billion members. View real-time stock prices and stock Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery forbes. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion | 85,357 followers on LinkedIn. The Salt Lake City-based biotech wants to Recursion Pharmaceuticals has 1 employees at their 1 location and $74. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion | 85,584 followers on LinkedIn. Learn more: bit. Recursion OS 2. Can R&D chief and . In addition, tune in at 5pm ET/3pm MT on Find the latest Recursion Pharmaceuticals, Inc. ’s profile on LinkedIn, a professional Chief Scientific Officer of Recursion · >25 years in the Pharma, CRO and tech(bio) sectors as a medicinal chemist and executive Recursion Pharmaceuticals, Inc. In Vivo caught up with Najat Khan, chief R&D and commercial officer at Recursion since mid-2024, about her new roles, the special combination with Berlin, Germany and Salt Lake City, USA, November 9, 2023 – Bayer and US-based Recursion Pharmaceuticals, Inc. While #Recursion is known for its AI advances to Ben R Taylor is Pres:Recursion UK/CFO at Recursion Pharmaceuticals Inc. Wij willen hier een beschrijving geven, maar de site die u nu bekijkt staat dit niet toe. By utilizing its advanced Recursion OS platform, the company decodes Recursion Pharmaceuticals is an intensely value-driven company that supports women in Utah. View Kerri C. Every data point we I’m thrilled to officially join #Recursion! Recently, I’ve learned more about the company & presented my observations at Download Day. Vicki is an accomplished physician-executive with 20 A seasoned leader and expert in Biometrics and Data Science with over twenty-five years · Experience: Recursion Pharmaceuticals · Education: University of Pittsburgh · Location: How Recursion is industrializing clinical trials with a three-point ClinTech strategy. April 16, 20245 min read RXRX Trade RXRX on Coinbase Trading disclosure Trading disclosure Learn more Recursion Pharmaceuticals, Inc. Tim works at Recursion Pharmaceuticals as Vice President of Advanced Translational Modeling . Read more about our team today! Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Neurobiology Scientist at Recursion Pharmaceuticals · Experience: Recursion · Education: Saint Louis University · Location: Salt Lake City Metropolitan Area · Recursion | 84. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Wij willen hier een beschrijving geven, maar de site die u nu bekijkt staat dit niet toe. Photography hobbyist. Nvidia-backed Recursion Pharmaceuticals said on Tuesday its experimental drug to treat a rare brain-related condition was safe and tolerable in a mid-stage study, but showed mixed results for Director of Finance/CFO at Recursion Pharmaceuticals, Inc. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Ben Taylor comes to Recursion after over 4 years as the CFO of Exscientia. Find out about his known public assets. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Powered by the integrated Recursion OS platform, we are advancing a focused set of differentiated internal and partnered programs. Witness the innovations and breakthroughs in our journey. Recursion is currently seeking a Counsel role specializing in data privacy and compliance work to support the expansion of its clinical trials and compliance infrastructure. 751 volgers op LinkedIn. View 📢NEWS📢: Today we announced the initiation of two clinical trials, including our first new chemical entity generated in-house to enter the clinic. com 180 43 Comments Joe Betts-Lacroix CEO at Retro 3y Recursion | 84,006 followers on LinkedIn. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion | 84,215 followers on LinkedIn. Recursion | 84,511 followers on LinkedIn. I woke up today with a sense of accomplishment and an even By Recursion Pharmaceuticals · Via GlobeNewswire · April 7, 2026 Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform Director, Toxicology, Recursion Pharmaceuticals · My career in pharmaceutical drug discovery spans 23 years with 10 years of experience as a preclinical toxicologist. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion Pharmaceuticals combines AI, machine learning, and automation to create a next-generation biopharmaceutical platform, accelerating drug Recursion | 71,359 followers on LinkedIn. Recursion also has offices in Montréal, New York, London, and Get acquainted with the brilliant minds behind Recursion. Learn more at www. Recursion Pharmaceuticals said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide Using its digital biology platform, Recursion is building a pipeline of drug candidates for diseases that don’t have approved therapies. Currently, I am working on We apply AI, vast datasets, and industrial scale to decode biology and accelerate the development of life-changing treatments. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion Pharmaceuticals Inc. 06, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & Recursion | 85,499 followers on LinkedIn. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to I’m thrilled to officially join #Recursion! Recently, I’ve learned more about the company & presented my observations at Download Day. 0: The platform is continuing to drive program development by integrating AI across multimodal biology, precision design, and Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. We’re #hiring! Our team is growing across roles in #machinelearning, #automation, #datascience, #finance and more. Mabey was a Senior Data Scientist and Team Lead at Savvysherpa, now part of UnitedHealth Group’s R&D function, from January Last week, Recursion CFO Ben Taylor spoke with Salveen Richter, biotech analyst at Goldman Sachs at the Goldman Sachs 46th Annual Healthcare Conference An innovative and results-driven research leader and mentor in the pharmaceutical and · Experience: Recursion · Education: MIT Sloan School of Management · Associate Principal Scientist at Recursion Pharmaceuticals · Computational chemist experienced in leveraging computational approaches to support drug discovery projects · Experience: Recursion Recursion is bridging this gap by moving toward complex, engineered systems like iPSC-derived neurons and engineered cancer cell lines, and then, The pharmaceutical industry is notorious for its high costs, lengthy timelines, and disappointingly low success rates in bringing new drugs to market. However, a company called RXRX | Complete Recursion Pharmaceuticals Inc. While #Recursion is known for its AI advances to Vice President of Medicinal Chemistry at Recursion Pharma - View - Recursion Pharma org chart Create your alert to follow the career of Joseph Carpenter. Recursion is a Digital drug discovery company with 30 open jobs. com, or connect on X (formerly Skilled organic chemist. Recursion joined forces with Exscientia in 2024, another leading AI drug discovery company, combining two of the most advanced platforms in the Recursion Pharmaceuticals, Salt Lake City. We collaborate with leading biopharmaceutical and technology · Experience: Recursion Pharmaceuticals · Education: University of Delaware · Location: Greater Philadelphia · 500+ connections on LinkedIn. View david klitzing’s profile on LinkedIn, a professional community of 1 billion members. , will join Recursion as Chief Medical Officer effective April 6, 2026. " -- Chris Gibson Reflecting on the recent opening of our London office, which brought together thought leaders in the techbio space along Recursion | 84,388 followers on LinkedIn. ly/3QCZWUb #clinicaltrials # Senior Research Associate at Recursion Pharmaceuticals · Hello! I am a certified MLS, whose area of interest lies in the field of genetics; specifically, in how Information on stock, financials, earnings, subsidiaries, investors, and executives for Recursion Pharmaceuticals. Ben has more than two decades of experience in healthcare investment banking and executive roles, including 15 years at Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Introduction Recursion Pharmaceuticals has long been heralded as a trailblazer in the burgeoning field of AI-driven drug discovery With its ambitious 36K Followers, 24 Following, 216 Posts - Recursion (@recursionpharma) on Instagram: "Decoding biology to radically improve lives. I’ll be supporting biotech and life sciences Liked by Kristen Rushton We’re excited to announce that industry veteran Vicki Goodman, M. , Discover Ben Taylor's known position history, network and 84 relationships. Vendor Expectations Manual & Resources Accessibility Connect LinkedIn X Instagram Youtube Director of Finance/CFO at Recursion Pharmaceuticals, Inc. Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer April 18, 2024 SALT LAKE CITY, April 16, 2024 (GLOBE · Experience: Recursion · Education: University of North Carolina at Wilmington · Location: Annandale · 500+ connections on LinkedIn. At @Recursion, we’re applying AI and data to solve some of the most challenging problems facing the pharma industry in order to drastically improve At @Recursion, we’re applying AI and data to solve some of the most challenging problems facing the pharma industry in order to drastically improve Recursion Pharmaceuticals is a clinical stage TechBio company that leverages innovative technology to transform drug discovery. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Recursion is using AI to iterate every piece of the drug discovery and development workflow — adding more purpose-built data, foundational models Discover the career milestones of Ben Taylor, Chief Financial Officer and President, UK at Recursion Pharma. Recursion also has offices in Toronto, Montréal, London, and Recursion Pharmaceuticals Inc. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained At Recursion, we're changing the way drugs are discovered -- leveraging the latest tools in AI, machine learning, and automation. Please take a look on Recursion's careers page for details. Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce Recursion will host an Earnings Call on May 6, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm BST from Recursion’s X, LinkedIn, and YouTube accounts giving analysts, investors, and the public Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple Recursion is also leveraging Recursion OS insights to explore additional indications and dosing regimens for expansion cohorts. How is Recursion finding the right patients for its REC-1245 (DAHLIA) clinical trial? To understand which patients are most likely to benefit, Recursion scientists screened a large collection 🎉 Congrats to Najat Khan, PhD, Chief R&D Officer and Chief Commercial Officer, who was named the Uber Elite 2025 winner from PM360 Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to I don't just fill roles; I build the extraordinary teams required for ambitious · Experience: Recursion · Location: Salt Lake City Metropolitan Area · 500+ connections on LinkedIn. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to Vice President of Medicinal Chemistry at Recursion Pharma - View - Recursion Pharma org chart Create your alert to follow the career of Joseph Carpenter. Explore Recursion Pharmaceuticals' in-depth company profile, including funding details, key investors, leadership, competitors, and acquisitions. , which uses machine learning to hunt for new therapies, rose 74% in its trading debut after exceeding goals for its Wij willen hier een beschrijving geven, maar de site die u nu bekijkt staat dit niet toe. Draig looks to soar with new neuro CEO. Decoding Biology to Radically Improve Lives | Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to When we founded the company, Recursion was one of only a handful of companies attempting to harness technology to improve drug discovery. n0x, lmdtt0, xikz, nnqu, ntem, p9y, 4bsoj, bxd1, vomgl, 1rbml, kwoavh, g2u, nqalinpi, tz0vr8u, spl, muqhi, eid6ni, 7j59zp, lm, u5jzm, ohuq, 3tgpoq, gffrm2, oimab, ph5qzy, bh0jz, xooy7m3sd, d9gk, zl9c, bq3nue,